New class of drug slows growth of castration-resistant prostate cancer cells
A first-in-class sphingosine kinase 2 inhibitor slowed the growth of castration-resistant prostate cancer cells, in…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
A first-in-class sphingosine kinase 2 inhibitor slowed the growth of castration-resistant prostate cancer cells, in…
Proton beam therapy—a more precise form of radiotherapy—to treat the childhood brain cancer medulloblastoma appears…
In a world-first clinical trial, Melbourne medical researchers have shown that patients with an advanced…
Women who eat more high-fibre foods during adolescence and young adulthood—especially lots of fruits and…
Cancer survivors of childhood brain tumours show significant deficits in intelligence, educational achievement and employment,…
Surgeons removing a malignant brain tumour don’t want to leave cancerous material behind. But they’re…
An outcomes study led by Alexi Wright, MD, MPH, a researcher and a gynecological oncologist in…
A new report estimates there were 4.3 million new cancer cases and more than 2.8…
A breast cancer patient is wheeled into the operating room. She is connected to an…
A discovery by UK researchers could lead to a better way to predict the risk of acute myeloid…